Moderna

MRNA · NASDAQ · USD

$185.98Change from previous close: −1.57%Absolute change: −$2.96

Close · October 2, 2026

At a glance

Revenue growth
−39.93%
2025 vs 2024
Net margin
-145.2%
2024: -110.0%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total revenue1453896781,0161421089661,8622411672,8111,831
Cost of revenue7387261,2271,0088199461,8611,6511,3361,1592,3353,401
Gross profit-593-337-5498.0-677-838-895211-1,095-992476-1,570
Selling, general and administrative216173308268230212351281268274470442
Research and development651649775801700———————
Operating income-809-510-857-260-907-1,050-1,246-70.0-1,363-1,2666.0-2,012
EBIT-809-510-857-260-907-1,050-1,246-70.0-1,363-1,2666.0-2,012
EBITDA-746-451-790-208-850-1,011-1,186-18.0-1,322-1,230208-1,763
Interest expense17.017.08.00.01.01.06.06.06.06.06.010.0
Pre-tax income-767-1,334-799-187-818-964-1,18421.0-1,279-1,16570.0-1,958
Income tax15.09.027.013.07.07.0-64.08.0—10.0-1471,672
Net income-782-1,343-826-200-825-971-1,12013.0-1,279-1,175217-3,630
Net income to common shareholders-782-1,343-826-200-825-971-1,12013.0-1,279-1,175217-3,630
Basic EPS-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.57-9.53
Diluted EPS-1.96-3.40-2.11-0.51-2.13-2.52-2.910.03-3.33-3.080.54-9.53
Average shares (basic)398395392390388386385385384382381381
Average shares (diluted)398395392390388386385399384382395381